Kevin Strauss
Pediatrics · Gordonville, PANPI 1760602437
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Novartis Gene Therapies, Inc. (fka Avexis, Inc.) accounts for 92.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $17,559 and has fallen 98.4% since, to $286 in 2024. Among pediatrics clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $322.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$44K
- Sarepta Therapeutics, Inc.$3K
- Genentech USA, Inc.$192
- Biomarin Pharmaceutical Inc.$152
- Biogen$144
- Novartis$111
- plus $227 from 7 others
Across 44 payments — averaging $21,076 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$295K
- Genentech, Inc.$236K
- Biomarin Pharmaceutical Inc.$230K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$117K
- Novartis$49K
What the payments were for
- Consulting fees$2,8006%
- Speaking & faculty fees$18,53439%
- Food & beverage$8042%
- Education$25,24653%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 117 | $43,724 |
| Sarepta Therapeutics, Inc. | 2 | $2,833 |
| Genentech USA, Inc. | 3 | $192 |
| Biomarin Pharmaceutical Inc. | 3 | $152 |
| Biogen | 5 | $144 |
| Novartis | 2 | $111 |
| Genentech, Inc. | 2 | $82 |
| Greenwich Biosciences, Inc. | 3 | $58 |
| PTC Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Neurelis, Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 6 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,384 in reported general payments places this provider in the 95th percentile of 1,849 pediatrics providers in Pennsylvania.
Other pediatrics in Gordonville
- Vincent CarsonGordonville$12K
- Craig CollisonSpring Mills$670K
- Arthur LeibowitzWynnewood$432K
- Jennifer CorenHatboro$410K
- Todd WolynnPittsburgh$275K
- Mark BlatterPittsburgh$238K
- Hoda Abdel HamidPittsburgh$101K
- Kristopher BossePhiladelphia$90K
- Binita Kamath PatelPhiladelphia$80K
- Martin BehmHatfield$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.